MEDI8852
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MEDI8852, covering 2015-07-13 to 2018-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza [Phase 1, Phase 2]